Angeles S. Feria-Galindo

Solna, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Plasma proteome reflects tissue damage and clinical manifestations in patients with inflammatory myopathies.

Plasma proteome reflects tissue damage and clinical manifestations in patients with inflammatory myopathies.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 07, 2026

Pan-disease blood protein profiles of rheumatic autoimmune diseases.

Pan-disease blood protein profiles of rheumatic autoimmune diseases.

Journal: Communications medicine

Published: December 12, 2025

Sera from patients with dermatomyositis and antisynthetase syndrome mediate muscle weakness, impair mitochondrial respiration and induce local cytokine production in muscle tissue.

Sera from patients with dermatomyositis and antisynthetase syndrome mediate muscle weakness, impair mitochondrial respiration and induce local cytokine production in muscle tissue.

Journal: Journal of autoimmunity

Published: October 23, 2025

Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase.

Autoreactive T cells identified in patients with anti-Jo1+ antisynthetase syndrome recognise a new epitope on histidyl t-RNA synthetase.

Journal: Annals of the rheumatic diseases

Published: August 01, 2025

Correction: Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome.

Correction: Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome.

Journal: Arthritis research & therapy

Published: December 02, 2024

Serum from patients with idiopathic inflammatory myopathy induces skeletal muscle weakness.

Serum from patients with idiopathic inflammatory myopathy induces skeletal muscle weakness.

Journal: Annals of the rheumatic diseases

Published: April 10, 2024

Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis.

Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis.

Journal: Rheumatology (Oxford, England)

Published: November 14, 2023

CD19-Targeting CAR T-Cell Therapy for Antisynthetase Syndrome.

CD19-Targeting CAR T-Cell Therapy for Antisynthetase Syndrome.

Journal: JAMA

Published: June 27, 2023

Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains.

Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains.

Journal: Rheumatology (Oxford, England)

Published: April 13, 2023

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies.

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies.

Journal: EBioMedicine

Published: March 07, 2023

Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathies.

Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathies.

Journal: EMBO molecular medicine

Published: November 29, 2022

Autoantibodies: Pathogenic or epiphenomenon.

Autoantibodies: Pathogenic or epiphenomenon.

Journal: Best practice & research. Clinical rheumatology

Published: July 09, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026